Repligen (RGEN) – Major News
-
Repligen (RGEN) Reports In-Line Q4 EPS, provides guidance
-
Repligen (RGEN) Tops Q3 EPS by 7c, Offers Guidance
-
Repligen (RGEN) Tops Q2 EPS by 5c, misses on revenue, provides guidance
-
Repligen (RGEN) Tops Q1 EPS by 5c, Lowers FY23 Guidance
-
Repligen (RGEN) Tops Q4 EPS by 10c, Guidance Falls Short of Conensus
-
Repligen (RGEN) Tops Q3 EPS by 9c. Updates Guidance
-
Repligen (RGEN) Tops Q2 EPS by 20c, Offers Guidance
-
Repligen (RGEN) Tops Q1 EPS by 20c; Lowers FY Outlook
-
Repligen (RGEN) Tops Q4 EPS by 16c
-
Repligen (RGEN) Tops Q3 EPS by 14c, Raises FY Guidance
-
Repligen (RGEN) Tops Q2 EPS by 27c
-
Repligen (RGEN) Tops Q1 EPS by 26c
-
Repligen (RGEN) Tops Q4 EPS by 21c, Offers FY Guidance
-
Repligen (RGEN) Tops Q3 EPS by 12c, Revenues Beat; Offers FY20 EPS/Revenue Guidance Above Consensus
-
Repligen (RGEN) Tops Q2 EPS by 15c, Revenues Beat; Raises FY20 EPS/Revenue Guidance Above Consensus
-
Repligen (RGEN) Tops Q1 EPS by 11c, Revenues Beat; Raises FY20 EPS Guidance Above Consensus, Reaffirms Revenue Views Above Consensus
-
Repligen (RGEN) Tops Q4 EPS by 2c, Revenues Beat; Offers FY20 EPS/Revenue Guidance
-
Repligen (RGEN) Tops Q3 EPS by 7c, Revenues Beat; Raises FY19 EPS/Revenue Guidance Above Consensus
-
Repligen (RGEN) Tops Q2 EPS by 6c, Revenues Beat; Raises FY19 EPS/Revenue Guidance
-
Repligen (RGEN) Tops Q1 EPS by 7c, Revenues Beat; Raises FY19 EPS/Revenue Guidance
-
Repligen (RGEN) Reports In-Line Q4 EPS, Offers Guidance
-
Repligen (RGEN) Tops Q3 EPS by 2c, Revenues Beat; Boosts FY18 EPS/Revenue Guidance
-
Repligen (RGEN) Misses Q2 EPS by 2c
-
Repligen (RGEN) Tops Q1 EPS by 2c, Beats on Revenues; Boosts FY18 EPS/Revenue Outlook
-
Repligen (RGEN) Tops Q4 EPS by 8c, Beats on Revenues; Offers FY18 EPS/Revenues Mid-Point Guidance Below Consensus
-
Repligen (RGEN) Tops Q3 EPS by 4c, Beats on Revenues; Offers FY EPS/Revenues Guidance
-
Repligen (RGEN) Tops Q2 EPS by 9c
-
Repligen (RGEN) to Acquire Spectrum in Cash and Stock Deal
-
Repligen (RGEN) Tops Q4 EPS by 1c
-
Repligen (RGEN) Reports In-Line Q3 EPS
-
Repligen (RGEN) Tops Q2 EPS by 3c
-
Repligen (RGEN) Tops Q1 EPS by 2c; Raises Outlook
-
Repligen (RGEN) Reports In-Line Q4 EPS
-
Repligen (RGEN) Reports In-Line Q3 EPS
-
Repligen (RGEN) Tops Q2 EPS by 3c
-
Repligen (RGEN) Tops Q1 EPS by 2c
-
Repligen (RGEN) Posts Q4 Loss of 1c/Share
-
Repligen (RGEN) Appoints New CEO
-
Repligen (RGEN) Reports In-Line Q3 EPS
-
Repligen Corp (RGEN) Tops Q1 EPS by 3c; Boosts FY14 Revs Outlook
-
Repligen Corp (RGEN) Misses Q4 EPS by 4c
-
Repligen Corp (RGEN) Tops Q3 EPS by 5c
-
Repligen Corp (RGEN) Tops Q2 EPS by 4c
-
Repligen Corp (RGEN) Reports Q1 EPS of $0.07; Guides FY13
-
Repligen Corp (RGEN) Swings to Q1 Profit of 4c/Share
-
Repligen Corp (RGEN) Swings to Q3 Loss
-
Repligen Corp (RGEN) Tops Q2 EPS by 4c
-
Repligen Corp (RGEN) Tops Q1 EPS by 1c
-
Repligen Corp (RGEN) Misses Q4 EPS by 3c, Raises FY12 Revenue Guidance
-
Repligen (RGEN) Guides FY11, FY12 Revenues Above the Street
Back to RGEN Stock Lookup